VR Logo

Parabolic Drugs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1996

Chairman: --

Managing Director: Pranav Gupta

Group: --

Listing: NSE: PARABDRUGS, BSE: 533211

Headquarters: Chandigarh, Punjab

Website: www.parabolicdrugs.com

Key Facts

Market cap: R 9.41 Cr

Revenue (TTM): R 5.23 Cr

Earnings (TTM): R -37.63 Cr

Cash: R 0.87 Cr

Total Debt: R 983.03 Cr

Promoters' ownership: 37.79%

Liquidity: Moderate

52 Week range: R 0.45 - 4.73

Face value: R10.00

Shares outstanding: 6,18,92,014

10 Years Aggregate:

  • CFO: 145.72 Cr
  • EBITDA: -424.10 Cr
  • Net Profit: -1,148.47 Cr

Stock Performance

Time Period Parabolic Drugs S&P BSE Healthcare S&P BSE Small Cap
YTD-43.3317.93-15.54
1 month-8.113.294.22
3 months54.5513.75-15.99
1 Year30.7717.97-22.54
3 Years-39.244.50-8.90
5 Years-28.48-0.111.33
10 Years--11.122.98
As on 03-Jun-2020
Year Parabolic Drugs S&P BSE Small Cap S&P BSE Healthcare
201915.38-6.85-3.55
2018-69.21-23.41-5.89
20176.2559.640.49
2016-26.611.77-12.88
2015-0.546.7615.06
201419.5969.2447.43
2013-35.62-11.2322.55